Population
Human rhinovirus type 2 (HRV2) and recombinant very-low-density lipoprotein receptor (VLDL-R) fragments
Design
Preclinical
Authors
Loading...
Structural details of VLDL-R–HRV2 engagement are hypothesis-generating; extends models of viral entry but should not yet guide practice.
The study reveals the structural mechanism by which the VLDL receptor binds to human rhinovirus type 2, showing that two adjacent viral proteins are stapled together by the receptor's second and third repeats.
Neumann et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: